Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Melatonin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Melatonin 10mg/5ml oral solution
0401010ADAACDCD
|
Melatonin | Melatonin | Central Nervous System | 798 |
|
Melatonin 5mg/5ml oral solution
0401010ADAADADA
|
Melatonin | Melatonin | Central Nervous System | 631 |
|
Melatonin 10mg capsules
0401010ADAAAKAK
|
Melatonin | Melatonin | Central Nervous System | 611 |
|
Melatonin 2.5mg/5ml oral solution
0401010ADAACFCF
|
Melatonin | Melatonin | Central Nervous System | 533 |
|
Melatonin 2mg/5ml oral suspension
0401010ADAABZBZ
|
Melatonin | Melatonin | Central Nervous System | 468 |
|
Melatonin 3mg/5ml oral solution
0401010ADAACACA
|
Melatonin | Melatonin | Central Nervous System | 463 |
|
Melatonin 5mg/5ml oral suspension
0401010ADAADEDE
|
Melatonin | Melatonin | Central Nervous System | 282 |
|
Melatonin 2mg/ml oral solution sugar free
0401010ADAADFDF
|
Melatonin | Melatonin | Central Nervous System | 281 |
|
Melatonin 3mg modified-release capsules
0401010ADAAAJAJ
|
Melatonin | Melatonin | Central Nervous System | 179 |
|
Melatonin 2.5mg/5ml oral suspension
0401010ADAACGCG
|
Melatonin | Melatonin | Central Nervous System | 177 |
|
Melatonin 1mg capsules
0401010ADAABQBQ
|
Melatonin | Melatonin | Central Nervous System | 168 |
|
Melatonin 3mg/5ml oral suspension
0401010ADAACBCB
|
Melatonin | Melatonin | Central Nervous System | 113 |
|
Melatonin 4mg/5ml oral suspension
0401010ADAADCDC
|
Melatonin | Melatonin | Central Nervous System | 108 |
|
Melatonin 2.5mg capsules
0401010ADAAAHAH
|
Melatonin | Melatonin | Central Nervous System | 106 |
|
Bio-Melatonin 3mg tablets
0401010ADBCBZCY
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 97 |
|
Melatonin 2mg modified-release capsules
0401010ADAACHCH
|
Melatonin | Melatonin | Central Nervous System | 59 |
|
Icenia Melatonin 3mg capsules
0401010ADBCCBBR
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 8 |
|
Melatonin 3mg modified-release tablets
0401010ADAAAQAQ
|
Melatonin | Melatonin | Central Nervous System | 8 |
|
Icenia Melatonin 2mg capsules
0401010ADBCCDAE
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 6 |
|
Melatonin 5mg/5ml oral solution (old)
0401010ADAADDDD
|
Melatonin | Melatonin | Central Nervous System | 5 |
|
Melatonin 2.5mg tablets
0401010ADAACRCR
|
Melatonin | Melatonin | Central Nervous System | 3 |
|
Icenia Melatonin 5mg capsules
0401010ADBCCEBS
|
Melatonin (Proprietary preparations) | Melatonin | Central Nervous System | 2 |
|
Melatonin 4mg capsules
0401010ADAAAUAU
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Melatonin 8mg capsules
0401010ADAABJBJ
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Melatonin 10mg tablets
0401010ADAACNCN
|
Melatonin | Melatonin | Central Nervous System | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.